ストックスクリーナーアプリを入手
0.4029
10.29%
0.0376
プレマーケット:
.40
-0.0029
-0.72%
前日終値:
$0.3653
開ける：
$0.371
24時間の取引高:
3.50M
Relative Volume:
1.66
時価総額：
$16.74M
収益：
$62.71M
当期純損益:
$-10.48M
株価収益率:
-0.6395
EPS:
-0.63
ネットキャッシュフロー:
$-13.77M
1週間 パフォーマンス:
-5.24%
1か月 パフォーマンス:
+19.91%
6か月 パフォーマンス:
-33.84%
1年 パフォーマンス:
-87.09%
1日の値動き範囲:
$0.371
$0.43
1週間の範囲:
$0.35
$0.43
52週間の値動き範囲:
$0.2179
$3.3654
Prophase Labs Inc Stock (PRPH) Company Profile
名前
Prophase Labs Inc
セクター
電話
(215) 345-0919
住所
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.4029 | 17.66M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-13 | ダウングレード | Dawson James | Buy → Neutral |
| 2021-01-20 | 開始されました | Dawson James | Buy |
Prophase Labs Inc (PRPH) 最新ニュース
Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com
ProPhase Labs Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire
Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks
ProPhase Labs explores reverse merger with digital asset company - Investing.com
ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail
ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan
What analysts say about ProPhase Labs Inc. stockExceptional trading performance - Autocar Professional
What drives ProPhase Labs Inc. stock priceMassive profits - Autocar Professional
Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest
Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest
What makes ProPhase Labs Inc. stock price move sharplyEarly Breakout Tracker - Newser
How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail
PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan
Prophase Labs Secures $1M in New Loan Agreements - TipRanks
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener
Prophase Labs Appoints Carolina Abenante as Director - TipRanks
ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK
ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan
ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
52,394 Shares in ProPhase Labs, Inc. (NASDAQ:PRPH) Acquired by Squarepoint Ops LLC - Defense World
ProPhase Labs Announces Formation of Clinical Science Advisory B - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Tes - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Test Commercialization | PRPH Stock News - GuruFocus
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform | PRPH Stock News - GuruFocus
ProPhase Labs Inc. Establishes Clinical Science Advisory Board to Advance BE-SmartTM Test for Esophageal Disease Detection - Nasdaq
ProPhase Labs forms advisory board for esophageal test - Investing.com
ProPhase Labs Announces Formation of Clinical Science - GlobeNewswire
ProPhase Labs Targets $14 Billion Market with Revolutionary Esophageal Cancer Detection Platform - Stock Titan
HBIXHarvest: Bitcoin Enhanced Income ETF - The Globe and Mail
ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges - TipRanks
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strat - GuruFocus
Prophase Labs Inc (PRPH) 財務データ
収益
当期純利益
現金流量
EPS
2.04%
1.25%
大文字化:
|
ボリューム (24 時間):